Effects of hemp seed alone and combined with aerobic exercise on metabolic parameters, oxidative stress, and neurotrophic factors in young sedentary men.
- 2022-09-17
- Journal of food biochemistry 46(12)
- Ali Mohammadrezaei
- Ali Kavakeb
- Mahdieh Abbasalizad-Farhangi
- Mehran Mesgari-Abbasi
- PubMed: 36114824
- DOI: 10.1111/jfbc.14417
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Population
- 48 sedentary young men in Tabriz, Iran
- Methods
- double-blind, placebo-controlled, randomized clinical trial; hemp seed supplement (two 1-g capsules daily), aerobic PA thrice weekly; groups: hemp seed, hemp seed + PA, PA + placebo, placebo
- Blinding
- Double-blind
- Duration
- from April to August
Research Insights
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Aerobic PA with hemp seed consumption caused a significant difference in weight, body mass index, fat mass, high-density lipoprotein, catalase, and BDNF compared with baseline.
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Aerobic PA with hemp seed consumption caused a significant difference in weight, body mass index, fat mass, high-density lipoprotein, catalase, and BDNF compared with baseline.
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
At the end of the study, fat mass, total cholesterol, low-density lipoproteins, and BDNF were significantly different between the groups.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Aerobic PA with hemp seed consumption caused a significant difference in weight, body mass index, fat mass, high-density lipoprotein, catalase, and BDNF compared with baseline.
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Aerobic PA with hemp seed consumption caused a significant difference in weight, body mass index, fat mass, high-density lipoprotein, catalase, and BDNF compared with baseline.
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Aerobic PA with hemp seed consumption caused a significant difference in weight, body mass index, fat mass, high-density lipoprotein, catalase, and BDNF compared with baseline.
- Effect
- Beneficial
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
At the end of the study, fat mass, total cholesterol, low-density lipoproteins, and BDNF were significantly different between the groups.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Levels of anthropometric indices, dietary intake, antioxidant markers, lipid profile, fasting blood sugar (FBS), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY), balance, reaction time, and sit-ups were evaluated for all participants at baseline and post-intervention.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)
Also, aerobic PA alone caused significant changes in body weight, fat mass, and triglyceride compared with baseline.
- Effect
- Neutral
- Effect size
- Small
- Dose
- 2 g/day (two 1-g capsules daily)